Fennec Pharmaceuticals Statistics Share Statistics Fennec Pharmaceuticals has 27.48M
shares outstanding. The number of shares has increased by 0.95%
in one year.
Shares Outstanding 27.48M Shares Change (YoY) 0.95% Shares Change (QoQ) 0.09% Owned by Institutions (%) 48.55% Shares Floating 23.21M Failed to Deliver (FTD) Shares 67 FTD / Avg. Volume 0.1%
Short Selling Information The latest short interest is 1.28M, so 4.6% of the outstanding
shares have been sold short.
Short Interest 1.28M Short % of Shares Out 4.6% Short % of Float 6.63% Short Ratio (days to cover) 18.78
Valuation Ratios The PE ratio is -395.64 and the forward
PE ratio is 13.45.
Fennec Pharmaceuticals's PEG ratio is
4.06.
PE Ratio -395.64 Forward PE 13.45 PS Ratio 3.63 Forward PS 3.4 PB Ratio -31.33 P/FCF Ratio 6.39 PEG Ratio 4.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Fennec Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 6.38,
with a Debt / Equity ratio of -3.51.
Current Ratio 6.38 Quick Ratio 6.22 Debt / Equity -3.51 Debt / EBITDA 5.37 Debt / FCF 0.72 Interest Coverage 0.63
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $1.49M Profits Per Employee $-13.63K Employee Count 32 Asset Turnover 1.06 Inventory Turnover 3
Taxes Income Tax 365K Effective Tax Rate -514.08%
Stock Price Statistics The stock price has increased by 60.15% in the
last 52 weeks. The beta is 0.58, so Fennec Pharmaceuticals's
price volatility has been higher than the market average.
Beta 0.58 52-Week Price Change 60.15% 50-Day Moving Average 8.63 200-Day Moving Average 7.07 Relative Strength Index (RSI) 50.16 Average Volume (20 Days) 64,009
Income Statement In the last 12 months, Fennec Pharmaceuticals had revenue of 47.54M
and earned -436K
in profits. Earnings per share was -0.02.
Revenue 47.54M Gross Profit 44.35M Operating Income 2.57M Net Income -436K EBITDA 3.6M EBIT 2.57M Earnings Per Share (EPS) -0.02
Full Income Statement Balance Sheet The company has 26.63M in cash and 19.34M in
debt, giving a net cash position of 7.29M.
Cash & Cash Equivalents 26.63M Total Debt 19.34M Net Cash 7.29M Retained Earnings -219.68M Total Assets 44.88M Working Capital 32.38M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 26.98M
and capital expenditures 0, giving a free cash flow of 26.98M.
Operating Cash Flow 26.98M Capital Expenditures n/a Free Cash Flow 26.98M FCF Per Share 0.99
Full Cash Flow Statement Margins Gross margin is 93.3%, with operating and profit margins of 5.4% and -0.92%.
Gross Margin 93.3% Operating Margin 5.4% Pretax Margin -0.15% Profit Margin -0.92% EBITDA Margin 7.57% EBIT Margin 5.4% FCF Margin 56.75%
Dividends & Yields FENC does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for FENC is $13.5,
which is 54.1% higher than the current price. The consensus rating is "Strong Buy".
Price Target $13.5 Price Target Difference 54.1% Analyst Consensus Strong Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Sep 9, 2014. It was a
backward
split with a ratio of 1:3.
Last Split Date Sep 9, 2014 Split Type backward Split Ratio 1:3
Scores Altman Z-Score -3.2 Piotroski F-Score 2
